Key takeaways
The coalition, co-led by Pennsylvania Attorney General Dave Sunday, North Carolina Attorney General Jeff Jackson, Connecticut Attorney General William Tong, and Ohio Attorney General Dave Yost, sent a letter to Meta on December 17, 2025, alleging that the company is permitting advertisers to use fabricated AI content to sell weight-loss drugs directly to consumers.
Fake images and spokespeople deceive consumers
According to the attorneys general, dozens of companies are using Meta's advertising tools to promote GLP-1 drugs such as Ozempic, Wegovy, and Rybelsus, with most products being non-FDA-approved or compounded versions.
The ads frequently employ unlabeled AI-generated content, including fabricated before-and-after comparison photos and nonexistent healthcare professionals.
"Pennsylvanians deserve honest information about their health, not A.I.-generated deception designed to push potentially unsafe products by exploiting customer insecurity," said Attorney General Sunday in a statement from the Pennsylvania Attorney General's office.
"The use of artificial intelligence to fabricate images, spokespeople, and medical claims crosses a line and makes these ads particularly dangerous."
One particularly egregious example cited by the coalition shows an AI-generated model allegedly losing 208 pounds in just three weeks.
Other ads feature fake AI-created law enforcement officers, nurses, and pharmacists lending false credibility to weight-loss claims.
While Meta has existing policies requiring pharmaceutical advertisers to disclose medical effectiveness information and target only adult audiences, the coalition argues the company is not sufficiently enforcing these rules.
Arizona Attorney General Kris Mayes, who joined the coalition, emphasized Meta's responsibility to protect users.
"Meta has a responsibility to take down these clearly fraudulent ads. We're simply urging them to enforce their own policies and take common-sense steps against misleading and dangerous AI-generated weight loss content," Mayes said in a statement.
The attorneys general note that many ads capitalize on people's body image concerns by promoting weight loss for purposes beyond health, such as self-confidence and desirability.
The ads often feature body close-ups and side-by-side comparisons while promoting rapid weight loss without disclosing the risks and side effects of these medications.
Demands for stricter advertising standards
The coalition is calling on Meta to implement several measures, including:
Restricting prescription drug ads in the United States to only FDA-approved products
Requiring all content promoting weight-loss products to clearly disclose risks and potential side effects
Prohibiting weight-loss drug ads that use AI-generated content
Developing better tools to detect and remove improperly labeled AI-generated content
Redirecting users to educational resources about weight-loss products when they search for them
Joining Arizona and the co-leading states, the coalition includes attorneys general from;
American Samoa
Arkansas
California
Delaware
District of Columbia
Hawaii
Illinois
Iowa, Kansas
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Dakota
Oklahoma
Oregon
Rhode Island
South Carolina
South Dakota
Utah
Vermont
Washington.
Read more:
OpenAI Releases GPT-5.2 Following Internal ‘Code Red’ Alert
Trump Signs Executive Order To Block State AI Regulations
Publishers Under Fire After ‘Fake’ Citations Found In AI ethics Guide
